RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG) | MicrobiomeTrials← Back to trialsNCT06305793
RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2024-03-11Est. Completion: 2026-03-23
Enrollment target: 200 participants Locations- All sites listed under NCT06305780, Durham, North Carolina, United States
Other microbiome trials you might be interested in
Post-Acute COVID-19 SyndromeFatigue
The primary objective of this study is to conduct a 16-week randomized controlled trial aimed at investigating the effec…
Baltimore, United StatesEst. completion Jun 30, 2028
Post-Acute COVID-19 Syndrome
Background:
SARS-CoV-2 is the virus that causes COVID-19. Some people who recover from an acute COVID-19 infection may …
Bethesda, United StatesEst. completion Jan 1, 2028
Completed
COVID-19 is a systemic inflammatory disease involving many organs including the lungs, vascular system liver and myocard…
Baltimore, United StatesCompleted May 15, 2026